<DOC>
	<DOCNO>NCT00846157</DOCNO>
	<brief_summary>Primary objective : - To compare event free survival 3years R-CHOP plus Biocell Natural Killer Cell R-CHOP therapy DLBCL patient .</brief_summary>
	<brief_title>Biocell Natural Killer Mixture Diffuse Large B Cell Lymphoma ( DLBCL ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>1 . Men woman age 20 70 2 . The patient measurable lesion use radiograph receive chemotherapy radiation therapy confirm DCBCL . 3 . The patient Ann arbor Ⅰ , Ⅱ , Ⅲ , Ⅳ 4 . The patient receive NK / TCell lymphocyte therapy . 5 . The patient expect survive least 3 month . 6 . The patient whose representative voluntary write informed consent performance studyrelated procedure . 7 . Women child bear potential must negative pregnancy test within 7 day prior study registration agree use adequate birth control study treatment . 8 . The patient ADL classification ( ECOG ) scale 0 , 1 , 2 9 . Patients satisfy follow hematologic criterion WBC ≥ 3,000 / ㎕ platelet count ≥ 75,000 / ㎕ serum total bilirubin ≤ two time upper limit normal value laboratory serum creatinine ≤ two time upper limit normal value laboratory 10. lymphoma patient satisfy follow criterion good renal function ( GFR &gt; 50 ) good hepatic function ( total bilirubin level ≤ three time upper limit normal value test laboratory transaminase ≤ 5 time upper limit normal value test laboratory ) 11 . The patient negative HIV surface antigen 12 . The patient negative HBV 13 . The patient negative HCV 14 . The patient receive immunotherapy . 15 . The patient experience tuberculosis infection within recent 6 month . 1 . The minor 20 year age ( In accordance Civil Code ) 2 . The patient diagnose type lymphoma 3 . The patient central nervous system meningeal involvement lymphoma . 4 . The patient contraindication chemotherapy regimen 5 . The patient another active severe disease . 6 . The patient history cancer within 5 year 7 . Uncontrolled hypertension patient 8 . The patient hypersensitivity Erythropoietin . 9 . The patient follow disease experience follow disease within 3 month . Myocardial infarction Unstable coronary disease Uncontrolled cardiac insufficiency . Venous thrombosis Pulmonary embolism 10 . The patient experience treat pharmaceutical clinical trial . 11 . Pregnant lactate woman woman childbearing age use adequate contraceptive method . 12 . The patient clinically serious bacterial , viral fungal infection 13 . The patient test group problem NK cell culture ( Investigator decide criteria basis generate NK cell culture ) 14 . Patients autoimmune disease 15 . The patient underwent visceral resection relate Lymphoma .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>natural killer cell</keyword>
	<keyword>DLBCL ( Diffuse Large B Cell Lymphoma )</keyword>
</DOC>